Renalytix Ai (RENX) Hits New 52-Week High at $145.00

Renalytix Ai PLC (LON:RENX) shares hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as GBX 145 ($1.89) and last traded at GBX 145 ($1.89), with a volume of 731 shares trading hands. The stock had previously closed at GBX 137.50 ($1.80).

In other Renalytix Ai news, insider Christopher H. B. Mills bought 5,970 shares of Renalytix Ai stock in a transaction dated Wednesday, December 19th. The shares were bought at an average price of GBX 103 ($1.35) per share, with a total value of £6,149.10 ($8,034.89).

COPYRIGHT VIOLATION NOTICE: “Renalytix Ai (RENX) Hits New 52-Week High at $145.00” was originally reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are reading this report on another site, it was illegally copied and republished in violation of US & international copyright legislation. The correct version of this report can be viewed at https://www.chaffeybreeze.com/2019/02/14/renalytix-ai-renx-hits-new-52-week-high-at-145-00.html.

About Renalytix Ai (LON:RENX)

Renalytix AI plc develops artificial intelligence (AI) enabled clinical decision support solutions for kidney disease. It is developing KidneyIntelX, an AI-enabled, clinical-laboratory based solution that supports physician decision making by improving identification, prediction, and risk stratification of patients with kidney disease.

Further Reading: Calculate Your Return on Investment (ROI)

Receive News & Ratings for Renalytix Ai Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Renalytix Ai and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply